The United States Food and Drug Administration (USFDA) has conducted an inspection at Unichem Laboratories’ Goa Formulation facility situated at Pilerne, Bardez. The inspection was conducted from September 21, 2026 to September 26, 2026. The inspection concluded with five observations related to procedural enhancements.
Unichem Laboratories is engaged in manufacturing formulations, pharmaceuticals and active pharmaceutical ingredients (APIs).